SEGMENTS (Tables)

6 Months Ended

Jun. 30, 2022

Segment Reporting [Abstract]

SCHEDULE OF SEGMENT INFORMATION

The following table summarizes the Company’s segment information for the following balance sheet dates presented, and for the six months ended June 30, 2022 and 2021:

	Real Estate			Digital Transformation Technology			Biohealth Business			Other			Total
Six Months Ended on June 30, 2022
Revenue	$	1,924,916		$	7,701		$	749,693		$	196,267		$	2,878,577
Cost of Sales		(1,625,942	)		(2,792	)		(11,985	)		(24,508	)		(1,665,227	)
Gross Margin		298,974			4,909			737,708			171,759			1,213,350
Operating Expenses		(1,320,957	)		(159,976	)		(910,246	)		(2,129,974	)		(4,521,153	)
Operating Loss		(1,021,983	)		(155,067	)		(172,538	)		(1,958,215	)		(3,307,803	)
Other Income (Expense)		209			(764,968	)		(3,039,097	)		(10,579,541	)		(14,383,397	)
Net Loss Before Income Tax		(1,021,774	)		(920,035	)		(3,211,635	)		(12,537,756	)		(17,691,200	)

	Real Estate			Digital Transformation Technology			Biohealth Business			Other			Total
Six Months Ended on June 30, 2021
Revenue	$	8,478,673		$	-		$	3,671,673		$	-		$	12,150,346
Cost of Sales		(6,125,201	)		-			(180,603	)		-			(6,305,804	)
Gross Margin		2,353,472			-			3,491,070			-			5,844,542
Operating Expenses		(625,555	)		(69,375	)		(1,910,582	)		(8,321,318	)		(10,926,830	)
Operating (Loss) Income		1,727,917			(69,375	)		1,580,488			(8,321,318	)		(5,082,288	)
Other Expense		(9,177	)		617,562			(28,743,495	)		(51,026,886	)		(79,161,996	)
Net Loss Before Income Tax		1,718,740			548,187			(27,163,007	)		(59,348,204	)		(84,244,284	)
June 30, 2022
Cash and Restricted Cash	$	3,007,823		$	214,976		$	2,442,236		$	36,331,232		$	41,996,267
Total Assets		47,101,961			1,475,948			7,025,365			120,468,046			176,071,320
December 31, 2021
Cash and Restricted Cash	$	7,493,921		$	245,780		$	2,629,464		$	50,433,014		$	60,802,179
Total Assets		55,465,600			2,199,466			11,056,779			115,488,298			184,210,143